BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 234 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,532,396 | -30.7% | 2,758,813 | -31.1% | 0.06% | -32.1% |
Q2 2023 | $28,193,088 | +6218.6% | 4,004,700 | +7385.4% | 0.08% | +8300.0% |
Q1 2023 | $446,190 | -98.0% | 53,500 | -97.3% | 0.00% | -98.7% |
Q4 2022 | $22,829,438 | +235.0% | 1,988,627 | +208.7% | 0.08% | +169.0% |
Q2 2022 | $6,815,000 | +1847.1% | 644,100 | +2448.7% | 0.03% | +2800.0% |
Q4 2021 | $350,000 | -88.1% | 25,272 | -87.6% | 0.00% | -92.3% |
Q3 2021 | $2,930,000 | -87.8% | 203,913 | -93.7% | 0.01% | -88.9% |
Q4 2020 | $24,069,000 | +1007.6% | 3,230,800 | +410.7% | 0.12% | +963.6% |
Q3 2020 | $2,173,000 | -48.6% | 632,600 | -28.7% | 0.01% | -60.7% |
Q2 2020 | $4,229,000 | -29.9% | 887,570 | -70.6% | 0.03% | -42.9% |
Q1 2020 | $6,036,000 | -79.1% | 3,018,132 | -64.0% | 0.05% | -67.8% |
Q4 2019 | $28,921,000 | +209.6% | 8,382,900 | +157.1% | 0.15% | +166.7% |
Q3 2019 | $9,340,000 | +2319.7% | 3,260,000 | +6770.0% | 0.06% | +2750.0% |
Q1 2019 | $386,000 | -86.3% | 47,453 | -86.4% | 0.00% | -85.7% |
Q4 2018 | $2,825,000 | -38.4% | 350,000 | -62.5% | 0.01% | -30.0% |
Q4 2017 | $4,585,000 | +15183.3% | 933,766 | +46588.3% | 0.02% | – |
Q2 2015 | $30,000 | – | 2,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 1,186,726 | $4,076,000 | 2.45% |
Sarissa Capital Management LP | 4,861,000 | $16,697,000 | 1.97% |
Ghost Tree Capital, LLC | 1,950,000 | $6,698,000 | 1.94% |
ORACLE INVESTMENT MANAGEMENT INC | 2,525,857 | $8,676,000 | 1.14% |
Eversept Partners, LP | 1,143,211 | $3,926,930 | 0.87% |
DAFNA Capital Management LLC | 749,051 | $2,573,000 | 0.84% |
KNOTT DAVID M | 397,361 | $1,365,000 | 0.80% |
Parkman Healthcare Partners LLC | 800,740 | $2,751,000 | 0.73% |
ACUTA CAPITAL PARTNERS, LLC | 660,000 | $2,267,000 | 0.62% |
Formidable Asset Management, LLC | 578,200 | $1,949,000 | 0.57% |